Mounting problems lie ahead of medical reform program.

Published: 2001-07-10 07:00:00

Updated: 2001-07-10 07:00:00

The revised bill of the pharmaceutical affairs law failed to pass through but put it to the next special session of the National Assembly in July that may not open due to the current tax probe over the major press companies, leaving, therefore, many problems unsolved, arising from the medical and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK